Global Biopsy Devices Market, By Type (Tissue Biopsy (By Product Type (Instruments (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires), Systems (Biopsy Guns, Vacuum Assisted Biopsy Systems)), By Biopsy Type, By Guidance Technology), Liquid Biopsy (By Product Type (CTC, CT DNA), By Application, By Product Type), By Distribution Channel, By End Users, By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
- Advertising -
Global Biopsy Devices Markethas accounted for USD 6.2 billion in 2016 growing at a CAGR of 14.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Major players operating in Global Biopsy Devices Market:
- Becton Dickinson and Company
- C.R Bard
- Argon Medical Devices, Inc.
- Cook Medical
- Gallini Srl
- Biocept, Inc.
- F Hoffmann La Roche
- Bio-Rad Laboratories, Inc.
- Myriad Genetics
- Jannsen Diagnostics LLC
- Trovagene Inc.
- Guardant Health Inc.
- MDX Health SA
Global Biopsy Devices Market Definition:
Biopsy devices market provides analysis value, volume sales and company share data for the products used in surgical interventions and critical care units. There was an increasing number of deaths in the last decade owing to excess anesthesia dosage with an advent and exposure of anesthesia monitoring and delivery systems healthcare providers are now able to curb the growth of these deaths.
- Advertising -
Major market drivers and restraints:
- Increasing aging population
- Increasing incidence of Cancer
- Government Initiatives to better healthcare
- Increasing focus on Cancer Diagnostics and early detection
- Technological development in liquid biopsy
- Government approvals to more products in the last decade
The global biopsy devices market is segmented on the basis of product type, application, end-user, and geography.
The biopsy devices market is segmented on the basis of type into tissue biopsy and liquid biopsy. Tissue biopsy still dominates the market in 2016, however the exceptional growth and increasing number of application approvals for liquid biopsy is expected to drive the growth of this market.
The tissue biopsy devices market segment is further segmented on the basis of product type, biopsy type, application, end user and guidance mode. On the basis of product type the market is segmented into instruments and systems.
The instrument sub segment is further sub segmented into biopsy needles, guidance systems, biopsy tables and localization wires. While the systems sub segment is further sub segmented into vacuum assisted biopsy systems and biopsy guns.
The liquid biopsy segment is further segmented on the basis of application, product type, and type of circulating biomarkers and by end-users. On the basis of product type the market is segmented into reagents and instruments.
On the basis of geography, biopsy devices market report covers data points for 28 countries across multiple The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. Asia Pacific is expected to grow at the highest CAGR of 23.7% in the forecast period 2017 to 2024.
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: